BMY financials
Bristol-Myers Squibb (BMY) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BMY income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $48.20B | $34.26B | $13.72B | $7.05B | 3.45 |
| 2024 | $48.30B | $34.33B | $5.89B | -$8.95B | -4.41 |
| 2023 | $45.01B | $34.31B | $8.20B | $8.03B | 3.86 |
| 2022 | $46.16B | $36.02B | $9.10B | $6.33B | 2.95 |
| 2021 | $46.38B | $36.45B | $8.54B | $6.99B | 3.12 |
| 2020 | $42.52B | $30.75B | $2.18B | -$9.02B | -3.98 |
- BMY revenue was $48.20B in fiscal 2025, net income $7.05B.
Updated 2026-11-02 19:12 UTC